WHO ICTRP trial
An open, multicenter, comparative study of pegylated interferon alpha-2a…
ChiCTR2000031665 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000031665 |
|---|---|
| Public title | An open, multicenter, comparative study of pegylated interferon alpha-2a combined with tenofovir disoproxil fumarate in treatment of chronic hepatitis B postpartum women. |
| Scientific title | An open, multicenter, comparative study of pegylated interferon alpha-2a combined with tenofovir disoproxil fumarate in treatment of chronic hepatitis B postpartum women. |
| Primary sponsor | Southern Hospital Affiliated to Southern Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Chronic hepatitis B |
| Interventions | A:Peg-IFN alpha-2a+TDF;B:TDF |
| Registration date | Apr 6, 2020 |
| Target size | A:110;B:110 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: